{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:17:14Z","timestamp":1788391034771,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":100,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Medical-Engineering Joint Fund between the First Affiliated Hospital of Dalian Medical University and Dalian Institute of Chemical Physics, Chinese Academy of Sciences.","award":["(Grant No. DMU-1&DICP UN202403)"],"award-info":[{"award-number":["(Grant No. DMU-1&DICP UN202403)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02434-9","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T17:05:26Z","timestamp":1779815126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the value of peritumoral brain zone for classification of two malignant brain tumors based on the MRI interpretable models"],"prefix":"10.1186","volume":"26","author":[{"given":"Endong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"2434_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. JAMA. 2023;329:574\u201387.","journal-title":"JAMA"},{"key":"2434_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41572-023-00439-0","volume":"9","author":"AJM Ferreri","year":"2023","unstructured":"Ferreri AJM, Calimeri T, Cwynarski K, et al. Primary central nervous system lymphoma. Nat Reviews Disease Primers. 2023;9:29.","journal-title":"Nat Reviews Disease Primers"},{"key":"2434_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231\u201351.","journal-title":"Neuro Oncol"},{"key":"2434_CR4","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM. Primary CNS Lymphoma. J Clin Oncol. 2017;35:2410\u20138.","journal-title":"J Clin Oncol"},{"key":"2434_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1634\/theoncologist.2008-0236","volume":"14","author":"M del Sierra","year":"2009","unstructured":"del Sierra M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Primary CNS Lymphoma in Immunocompetent Patients. Oncologist. 2009;14:526\u201339.","journal-title":"Oncologist"},{"key":"2434_CR6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3171\/2015.5.JNS142087","volume":"124","author":"YM Li","year":"2016","unstructured":"Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg JNS. 2016;124:977\u201388.","journal-title":"J Neurosurg JNS"},{"key":"2434_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3171\/2012.8.JNS12234","volume":"117","author":"D Orringer","year":"2012","unstructured":"Orringer D, Lau D, Khatri S, et al. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival: Clinical article. J Neurosurg JNS. 2012;117:851\u20139.","journal-title":"J Neurosurg JNS"},{"key":"2434_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1148\/radiol.2432060493","volume":"243","author":"RN Al-Okaili","year":"2007","unstructured":"Al-Okaili RN, Krejza J, Woo JH, et al. Intraaxial brain masses: MR imaging-based diagnostic strategy\u2013initial experience. Radiology. 2007;243:539\u201350.","journal-title":"Radiology"},{"key":"2434_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1212\/WNL.57.3.393","volume":"57","author":"U B\u00fchring","year":"2001","unstructured":"B\u00fchring U, Herrlinger U, Krings T, Thiex R, Weller M, K\u00fcker W. MRI features of primary central nervous system lymphomas at presentation. Neurology. 2001;57:393.","journal-title":"Neurology"},{"key":"2434_CR10","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3174\/ajnr.A2171","volume":"32","author":"IS Haldorsen","year":"2011","unstructured":"Haldorsen IS, Espeland A, Larsson EM. Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging. Am J Neuroradiol. 2011;32:984.","journal-title":"Am J Neuroradiol"},{"key":"2434_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jmri.27344","volume":"53","author":"W Xia","year":"2021","unstructured":"Xia W, Hu B, Li H, et al. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation. J Magn Reson Imaging. 2021;53:242\u201350.","journal-title":"J Magn Reson Imaging"},{"key":"2434_CR12","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/jmri.27592","volume":"54","author":"W Xia","year":"2021","unstructured":"Xia W, Hu B, Li H, et al. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System Lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model. J Magn Reson Imaging. 2021;54:880\u20137.","journal-title":"J Magn Reson Imaging"},{"key":"2434_CR13","doi-asserted-by":"crossref","unstructured":"Feng A, Li L, Huang T, et al. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: a comparative study. Heliyon 2023;9.","DOI":"10.1016\/j.heliyon.2023.e15150"},{"key":"2434_CR14","first-page":"1251","volume":"20","author":"D Kang","year":"2018","unstructured":"Kang D, Park JE, Kim Y-H, et al. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation. Neurooncology. 2018;20:1251\u201361.","journal-title":"Neurooncology"},{"key":"2434_CR15","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1007\/s00330-023-09681-2","volume":"33","author":"X Yu","year":"2023","unstructured":"Yu X, Hong W, Ye M, et al. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling. Eur Radiol. 2023;33:5357\u201367.","journal-title":"Eur Radiol"},{"key":"2434_CR16","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s00330-016-4484-2","volume":"27","author":"YS Choi","year":"2017","unstructured":"Choi YS, Lee H-J, Ahn SS, et al. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient. Eur Radiol. 2017;27:1344\u201351.","journal-title":"Eur Radiol"},{"key":"2434_CR17","doi-asserted-by":"crossref","unstructured":"Han Y, Wang Z-J, Li W-H, et al. Differentiation between primary central nervous system lymphoma and atypical glioblastoma based on mri morphological feature and signal intensity ratio: a retrospective multicenter study. Frontiers in Oncology. 2022;12.","DOI":"10.3389\/fonc.2022.811197"},{"key":"2434_CR18","doi-asserted-by":"publisher","first-page":"101912","DOI":"10.1016\/j.nicl.2019.101912","volume":"23","author":"Z Kong","year":"2019","unstructured":"Kong Z, Jiang C, Zhu R, et al. 18F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma. NeuroImage: Clin. 2019;23:101912.","journal-title":"NeuroImage: Clin"},{"key":"2434_CR19","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1007\/s00330-018-5368-4","volume":"28","author":"HB Suh","year":"2018","unstructured":"Suh HB, Choi YS, Bae S, et al. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach. Eur Radiol. 2018;28:3832\u20139.","journal-title":"Eur Radiol"},{"key":"2434_CR20","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1007\/s00330-019-06097-9","volume":"29","author":"JY Lee","year":"2019","unstructured":"Lee JY, Bj\u00f8rnerud A, Park JE, Lee BE, Kim JH, Kim HS. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma. Eur Radiol. 2019;29:5539\u201348.","journal-title":"Eur Radiol"},{"key":"2434_CR21","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s00330-018-5359-5","volume":"28","author":"S-H You","year":"2018","unstructured":"You S-H, Yun TJ, Choi HJ, et al. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging. Eur Radiol. 2018;28:3801\u201310.","journal-title":"Eur Radiol"},{"key":"2434_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00330-015-3805-1","volume":"26","author":"S Jiang","year":"2016","unstructured":"Jiang S, Yu H, Wang X, et al. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. Eur Radiol. 2016;26:64\u201371.","journal-title":"Eur Radiol"},{"key":"2434_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10143-025-03419-y","volume":"48","author":"I Mohammadzadeh","year":"2025","unstructured":"Mohammadzadeh I, Hajikarimloo B, Niroomand B, et al. Application of artificial intelligence in forecasting survival in high-grade glioma: systematic review and meta-analysis involving 79,638 participants. Neurosurg Rev. 2025;48:240.","journal-title":"Neurosurg Rev"},{"key":"2434_CR24","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1109\/TNNLS.2020.3027314","volume":"32","author":"E Tjoa","year":"2021","unstructured":"Tjoa E, Guan C. A Survey on Explainable Artificial Intelligence (XAI): Toward Medical XAI. IEEE Trans Neural Networks Learn Syst. 2021;32:4793\u2013813.","journal-title":"IEEE Trans Neural Networks Learn Syst"},{"key":"2434_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10916-021-01736-5","volume":"45","author":"J Peng","year":"2021","unstructured":"Peng J, Zou K, Zhou M, et al. An Explainable Artificial Intelligence Framework for the Deterioration Risk Prediction of Hepatitis Patients. J Med Syst. 2021;45:61.","journal-title":"J Med Syst"},{"key":"2434_CR26","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1038\/s41598-023-35557-y","volume":"13","author":"M Schinkel","year":"2023","unstructured":"Schinkel M, Bennis FC, Boerman AW, Wiersinga WJ, Nanayakkara PWB. Embracing cohort heterogeneity in clinical machine learning development: a step toward generalizable models. Sci Rep. 2023;13:8363.","journal-title":"Sci Rep"},{"key":"2434_CR27","doi-asserted-by":"publisher","first-page":"12764","DOI":"10.1038\/s41598-022-16514-7","volume":"12","author":"J Rudolph","year":"2022","unstructured":"Rudolph J, Schachtner B, Fink N, et al. Clinically focused multi-cohort benchmarking as a tool for external validation of artificial intelligence algorithm performance in basic chest radiography analysis. Sci Rep. 2022;12:12764.","journal-title":"Sci Rep"},{"key":"2434_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","volume":"6","author":"ER Gerstner","year":"2009","unstructured":"Gerstner ER, Duda DG, di Tomaso E, et al. VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Reviews Clin Oncol. 2009;6:229\u201336.","journal-title":"Nat Reviews Clin Oncol"},{"key":"2434_CR29","first-page":"1525","volume":"17","author":"P Wangaryattawanich","year":"2015","unstructured":"Wangaryattawanich P, Hatami M, Wang J, et al. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival. Neurooncology. 2015;17:1525\u201337.","journal-title":"Neurooncology"},{"key":"2434_CR30","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1007\/s00330-016-4637-3","volume":"27","author":"P Prasanna","year":"2017","unstructured":"Prasanna P, Patel J, Partovi S, Madabhushi A, Tiwari P. Radiomic features from the peritumoral brain parenchyma on treatment-na\u00efve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings. Eur Radiol. 2017;27:4188\u201397.","journal-title":"Eur Radiol"},{"key":"2434_CR31","first-page":"1322","volume":"17","author":"J-M Lem\u00e9e","year":"2015","unstructured":"Lem\u00e9e J-M, Clavreul A, Menei P. Intratumoral heterogeneity in glioblastoma: don\u2019t forget the peritumoral brain zone. Neurooncology. 2015;17:1322\u201332.","journal-title":"Neurooncology"},{"key":"2434_CR32","doi-asserted-by":"publisher","first-page":"838670","DOI":"10.3389\/fonc.2022.838670","volume":"12","author":"X Bai","year":"2022","unstructured":"Bai X, Zhou M. The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers. Front Oncol. 2022;12:838670.","journal-title":"Front Oncol"},{"key":"2434_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40644-016-0098-9","volume":"16","author":"H Malikova","year":"2016","unstructured":"Malikova H, Koubska E, Weichet J, et al. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma? Cancer Imaging. 2016;16:40.","journal-title":"Cancer Imaging"},{"key":"2434_CR34","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41598-020-67080-9","volume":"10","author":"Y-X He","year":"2020","unstructured":"He Y-X, Qu C-X, He Y-Y, Shao J, Gao Q. Conventional MR and DW imaging findings of cerebellar primary CNS lymphoma: comparison with high-grade glioma. Sci Rep. 2020;10:10007.","journal-title":"Sci Rep"},{"key":"2434_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15:155\u201363.","journal-title":"J Chiropr Med"},{"key":"2434_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1148\/radiol.2020191145","volume":"295","author":"A Zwanenburg","year":"2020","unstructured":"Zwanenburg A, Valli\u00e8res M, Abdalah MA, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020;295:328\u201338.","journal-title":"Radiology"},{"key":"2434_CR37","doi-asserted-by":"crossref","unstructured":"Bhagat RC, Patil SS. Enhanced SMOTE algorithm for classification of imbalanced big-data using random forest 2015. IEEE International Advance Computing Conference (IACC). 2015;403\u2013408.","DOI":"10.1109\/IADCC.2015.7154739"},{"key":"2434_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.procs.2023.01.025","volume":"218","author":"M Minnoor","year":"2023","unstructured":"Minnoor M, Baths V. Diagnosis of Breast Cancer Using Random Forests. Procedia Comput Sci. 2023;218:429\u201337.","journal-title":"Procedia Comput Sci"},{"key":"2434_CR39","unstructured":"Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Proceedings of the 31st International Conference on Neural Information Processing Systems. Curran Associates Inc., Long Beach, California, USA. 2017;4768\u20134777."},{"key":"2434_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10014-010-0275-7","volume":"27","author":"T Yamahara","year":"2010","unstructured":"Yamahara T, Numa Y, Oishi T, et al. Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging. Brain Tumor Pathol. 2010;27:81\u20137.","journal-title":"Brain Tumor Pathol"},{"key":"2434_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.30.9.907","volume":"30","author":"HH Fred","year":"1980","unstructured":"Fred HH, Amy P. Assumptions in the radiotherapy of glioblastoma. Neurology. 1980;30:907.","journal-title":"Neurology"},{"key":"2434_CR42","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/j.1349-7006.2009.01259.x","volume":"100","author":"T Engelhorn","year":"2009","unstructured":"Engelhorn T, Savaskan NE, Schwarz MA, et al. Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci. 2009;100:1856\u201362.","journal-title":"Cancer Sci"},{"key":"2434_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-026-01018-8","author":"F Yu","year":"2026","unstructured":"Yu F, Yuan J, Lin X, et al. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: CT vs MRI. Cancer Imaging. 2026. https:\/\/doi.org\/10.1186\/s40644-026-01018-8.","journal-title":"Cancer Imaging"},{"key":"2434_CR44","doi-asserted-by":"publisher","first-page":"124050","DOI":"10.1016\/j.wneu.2025.124050","volume":"198","author":"I Mohammadzadeh","year":"2025","unstructured":"Mohammadzadeh I, Hajikarimloo B, Niroomand B, et al. Artificial Intelligence\u2013Based Radiomic Model in Craniopharyngiomas: A Systematic Review and Meta-Analysis on Diagnosis, Segmentation, and Classification. World Neurosurg. 2025;198:124050.","journal-title":"World Neurosurg"},{"key":"2434_CR45","doi-asserted-by":"publisher","first-page":"105003","DOI":"10.1088\/1361-6560\/abf38b","volume":"66","author":"M Jiang","year":"2021","unstructured":"Jiang M, Han L, Sun H, et al. Cross-modality image feature fusion diagnosis in breast cancer. Phys Med Biol. 2021;66:105003.","journal-title":"Phys Med Biol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02434-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02434-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:42:44Z","timestamp":1788388964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02434-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2434"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02434-9","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional Ethics Committee of the Second Affiliated Hospital of Dalian Medical University (Approval No. 2023\u2009\u2212\u2009235) and the institutional Ethics Committee of the First Affiliated Hospital of Dalian Medical University (Approval No. PJ-KS-KY-2023-422). The requirement for written informed consent from patients was waived. The entire study process followed the principles outlined in the Helsinki Declaration.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"433"}}